HDACi like romidepsin is well known to induce p21 in p53-null ovarian cancer cells [32, 33], which can suppress the Akt-induced Mdm2 followed by slower cell proliferation and lower mortality rate (Figure 8D). Here, CDKN1A is linked to ovarian carcinoma.